Results 1 - 10 of 109 (Click here to explore results)

<

1

2

3

...

10

11

>

Chemiluminescence determination of naltrexone based on potassium permanganate oxidation. A. Campiglio , Analyst , 1998 , 123 , 1053

Nalmefene non-enantioselectively targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signaling: wet-lab techniques and in silico simulations. Xiaozheng Zhang, Hongshuang Wang, Yibo Wang, Hongyuan Li, Siru Wu, Jingwei Gao, Tianshu Zhang, Jun Xie, Xiaohui Wang , Phys. Chem. Chem. Phys. , 2021 , 23 , 12260

Asymmetric synthesis of (−)-naltrexone. Sun Dongbang, Blaine Pedersen, Jonathan A. Ellman , Chem. Sci. , 2019 , 10 , 535

A bivalent ligand targeting the putative mu opioid receptor and chemokine receptor CCR5 heterodimer: binding affinity versus functional activities. Yunyun Yuan, Christopher K. Arnatt, Nazira El-Hage, Seth M. Dever, Joanna C. Jacob, Dana E. Selley, Kurt F. Hauser, Yan Zhang , Med. Chem. Commun. , 2013 , 4 , 847

Molecular determinants for drug–receptor interactions. Part 13. X-Ray molecular structure of naltrexone malonate and quantum chemical studies of the conformations of the pure narcotic antagonists naloxone and naltrexone. Maria E. Amato, Giuliano Bandoli, Antonio Grassi, Marino Nicolini, Giuseppe C. Pappalardo , J. Chem. Soc., Perkin Trans. 2 , 1990 , 1757

Improved synthesis of 14-hydroxy opioid pharmaceuticals and intermediates. Gaik B. Kok, Peter J. Scammells , RSC Adv. , 2012 , 2 , 11318

Design, synthesis, and biological evaluation of C6-difluoromethylenated epoxymorphinan Mu opioid receptor antagonists. Andrew J. Kassick, Anny Treat, Nestor Tomycz, Michael G. Feasel, Benedict J. Kolber, Saadyah Averick , RSC Med. Chem. , 2022 , 13 , 175

A homogeneous single-label quenching resonance energy transfer assay for a δ-opioid receptor–ligand using intact cells. Kari Kopra, Shweta, Eija Martikkala, Pekka Hänninen, Ulla Petäjä-Repo, Harri Härmä , Analyst , 2013 , 138 , 4907

Design and synthesis of a bivalent ligand to explore the putative heterodimerization of the mu opioid receptor and the chemokine receptor CCR5. Yunyun Yuan, Christopher K. Arnatt, Guo Li, Kendra M. Haney, Derong Ding, Joanna C. Jacob, Dana E. Selley, Yan Zhang , Org. Biomol. Chem. , 2012 , 10 , 2633

Design and synthesis of a bivalent probe targeting the putative mu opioid receptor and chemokine receptor CXCR4 heterodimer. Bethany A. Reinecke, Guifeng Kang, Yi Zheng, Samuel Obeng, Huijun Zhang, Dana E. Selley, Jing An, Yan Zhang , RSC Med. Chem. , 2020 , 11 , 125